Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-899-1 | CAS number: 75-76-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In a gas modified bacterial reverse mutation assay / Ames test, conducted according to OECD Test Guideline 471 and in compliance with GLP (Laboratory of Pharmacology and Toxicology KG, 2002, reliability score 1), tetramethylsilane (CAS No. 75 -76 -3, EC No. 200-899 -1) at 99.8% purity was found to be negative in both the presence and absence of metabolic activation. The tested strains included Salmonella typhimurium: TA98, TA100, TA102, TA1535 and TA1537.
In a supporting gas modified bacterial reverse mutation assay / Ames Test conducted according to OECD 471 and in compliance with GLP (Hüls, 1997, reliability score 2), tetramethylsilane was found to be positive in both the presence and absence of metabolic activation for S. typhimurium strain TA1535 and negative for TA98, TA100 and TA1537. Only four strains of Salmonella typhimurium were tested resulting in a lower reliability score for this study and the test substance purity was lower than that used in the key study (92.2%).
In an in vitro cytogenicity study in mammalian cells (chromosome aberration), conducted according to OECD Test Guideline 473 and in compliance with GLP (Hüls, 1998, reliability score 1), the potential of tetramethylsilane to induce structural chromosome aberrations in Chinese hamster V79 cells was evaluated and found to be negative. No dose-related increases in the number of aberrations were observed at any of the concentrations tested with and without metabolic activation. Appropriate solvent and positive controls were included and gave expected results.
In an in vitro mutagenicity study, conducted according to OECD Test Guideline 476 and in compliance with GLP (Hüls, 1999, reliability score 1), the test substance was negative for mutagenicity in mammalian (CHO-K-1) cells with and without metabolic activation.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2002-05-06 to 2002-08-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium, other: TA 98, TA 100, TA 102, TA 1535, TA1537
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- 100-5000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: none given in report - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA 1535, TA 100 without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA 98 without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA 1537 without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- TA 102 without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-anthracene amide
- Remarks:
- TA 98, TA102, TA 1537 with metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- TA 100, TA 1535 with metabolic activation
- Details on test system and experimental conditions:
- ACTIVATION: Aroclor induced rat liver S9; NADP and glucose-6-phosphate as cofactors; S9 mix contained 5% S9; 0.5 ml S9 mix added to 2.2 ml agar/cell suspension/test material
METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 hours
- Expression time (cells in growth medium): 48 hours
SELECTION AGENT (mutation assays): minimal agar
NUMBER OF REPLICATIONS: 3 plates per concentration; 2 independent experiments, the first plate incorporation, the second pre-incubation
NUMBER OF CELLS EVALUATED: 10 E07 to 10 E08 cells
DETERMINATION OF CYTOTOXICITY
- Method: other: condition of bacterial lawn - Evaluation criteria:
- A chemical is considered positive if there is a reproducible dose-related statistically significant increase in the number of revertants compared with solvent control to at least 2 fold (strains TA 98, TA100 and TA 102) or 3-fold (strains TA 1535 and TA 1537). In addition, the histidine independence of the revertants has to be confirmed.
- Statistics:
- Statistically significant: p = 0.05: in U-test (Mann and Whitney) for inc in number of revertants; in Spearman's rank correlation coefficient for dose-related effect.
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 3160 µg/plate (pre-incubation experiment only)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 5000 µg/plate (pre-incubation experiment only)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 5000 µg/plate (Pre-incubation experiment only)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 5000 µg/plate (pre-incubation experiment only)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- At 5000 µg/plate (pre-incubation experiment only)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- Negative with and without metabolic activation
Tetramethylsilane was tested in a valid study according to OECD 471 and under GLP. No increase in the number of revertants was observed in the plate incorporation assay with and without metabolic activation. These results were confirmed in the repeat pre-incubation experiment, also with and without metabolic activation. Vehicle and positive controls gave expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the test. - Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-07-30 to 1998-11-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 1998
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital and beta-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- Test 1: 23,102, 187 µg/ml(-S9), 59, 260, ~500 µg/ml (+S9); Test 2: 25, 116, ~100 (-S9), 69, 260, 511 (+S9)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: culture medium
- Justification for choice of solvent/vehicle: none given in report - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- ACTIVATION: S9 mix contained NADP as cofactor
METHOD OF APPLICATION: other: the gaseous test substance was injected into the tightly closed cell culture flasks through a septum. At the end of the incubation period samples of the gaseous phase were withdrawn and concentration in medium determined from gas chromatography of the sample and the known air/medium distribution coefficient.
DURATION
- Preincubation period: none
- Exposure duration: 3 hours. In with metabolic activation assay the medium was exchanged at the end of this period by medium without S9.
- Expression time (cells in growth medium): 17 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 20 hours
SPINDLE INHIBITOR (cytogenetic assays): Colcemid added 2 hours before cell preparation
STAIN (for cytogenetic assays): Giesma
NUMBER OF REPLICATIONS: duplicate cultures, experiment repeated
NUMBER OF CELLS EVALUATED: 2000 cells were evaluated for determination of mitotic index; 100 cells per culture were analysed for chromosome aberrations.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A substance was considered positive if it induced a statistically significant increase in one or more concentrations at levels exceeding the normal range of the test system (>>5%).
- Statistics:
- Chi-square: statistically significant. if p < 0.05
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at ca 500 µl/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- Tetramethylsilane has been tested in a valid and reliable study according to OECD Test Guideline 473 and in compliance with GLP and found to be negative with and without metabolic activation. The volatility of the substance was taken into account in the study: exposure was in sealed flasks and an analytical determination of the concentrations by head space analysis was carried out at the end of the incubation period. No increase in the number of cells with aberrations was observed. Positive and vehicle controls produced expected results. It is concluded that the test substance is negative for the induction of chromosome aberrations under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HGPRT
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital and beta-naphthoflavone activated rat liver S9
- Test concentrations with justification for top dose:
- Test 1: 9-215 µg/ml (-S9), 28-543 µg/ml (+S9); Test 2 12-2125 µg/ml (-S9), 28-534 µg/ml (+S9)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: none
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- no
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- ACTIVATION: Phenobarbitol/beta-naphthoflavone activated rat liver S9, NADP as cofactor
METHOD OF APPLICATION: other: the gaseous test substance was injected into the tightly closed cell culture flasks through a septum. At the end of the incubation period samples of the gaseous phase were withdrawn and concentration in medium determined from gas chromatography of the sample and the known air/medium distribution coefficient.
METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Preincubation period: none
- Exposure duration: 4 hours
- Expression time (cells in growth medium): 9 days
- Selection time (if incubation with a selection agent): 6-7 days
- Fixation time (start of exposure up to fixation or harvest of cells): 15-26 days
SELECTION AGENT (mutation assays): 6-thioguanine
NUMBER OF REPLICATIONS: 2 flasks per concentration were treated, then pooled and 3 dishes per culture were plated for determination of cloning efficiency, 5 cultures per treatment group
NUMBER OF CELLS EVALUATED: 5 x 10 E05 (mutant frequency)
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- A substance is mutagenic if it causes a statistically significant dose related increase in mutant frequency at concentrations of the test substance resulting in > 20% cell survival. The increase is only considered biologically significant if it exceeds the spontaneous mutant frequency.
- Statistics:
- T-test ("Two sample analysis")
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not applicable
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- Tetramethylsilane was tested in a valid and reliable study according to OECD Test Guideline 476 and in compliance with GLP and found to be negative with and without activation. The volatility of the substance was taken into account in the study: exposure was in sealed flasks and an analytical determination of the concentrations by head space analysis was carried out at the end of the incubation period. The statistically significant increase in the number of revertants was neither dose related nor exceeding historical negative control values, and the increase in the presence of S9 was not reproducible. It is concluded that the test substance is negative for mutagenicity to mammalian cells under the conditions of the test.
Referenceopen allclose all
Table 1 Experiment 1 Plate incorporation: Number of revertants per plate (mean of 3 plates)
Concentration µg/plate |
TA 98 |
TA 100 |
TA 102 |
TA 1535 |
TA 1537 |
|||||
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
|
5000 |
35.7 |
41.0 |
132.3 |
128.3 |
269.3 |
310.3 |
11.7 |
12.0 |
8.0 |
7.0 |
3160 |
31.3 |
38.0 |
128.7 |
136.7 |
259.3 |
302.7 |
12.3 |
11.3 |
6.3 |
7.3 |
1000 |
34.7 |
36.0 |
117.0 |
125.0 |
258.7 |
300.0 |
11.7 |
11.0 |
5.7 |
7.7 |
316 |
31.7 |
37.3 |
116.7 |
126.0 |
310.7 |
307.3 |
11.0 |
11.7 |
5.3 |
6.3 |
100 |
25.0 |
39.7 |
134.3 |
144.0 |
276.7 |
280.7 |
11.3 |
12.7 |
4.0 |
5.0 |
0** |
36.0 |
42.0 |
127.0 |
122.7 |
265.0 |
298.3 |
12.3 |
11.3 |
5.7 |
6.3 |
Positive control |
986.3 |
990.3 |
1206.3 |
1196.7 |
1005.0 |
1135.0 |
213.3 |
207.0 |
207.7 |
208.7 |
** Solvent control with DMSO
Table 2 Experiment 2 Pre-incubation: Number of revertants per plate (mean of 3 plates)
Concentration µg/plate |
TA 98 |
TA 100 |
TA 102 |
TA 1535 |
TA 1537 |
|||||
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
-MA |
+MA |
|
5000 |
33.7* |
0.0* |
122.3* |
118.0* |
261.0* |
281.3* |
12.3* |
15.0* |
3.3* |
0.0* |
3160 |
38.3* |
27.7* |
143.3 |
122.0 |
274.7 |
278.7 |
11.7 |
14.7 |
3.0 |
4.0 |
1000 |
39.7 |
36.3 |
148.0 |
151.7 |
250.3 |
265.0 |
10.7 |
15.3 |
2.7 |
2.7 |
316 |
50.7 |
30.0 |
141.0 |
154.3 |
282.0 |
287.3 |
12.0 |
13.3 |
3.0 |
3.3 |
100 |
38.0 |
31.0 |
145.7 |
159.0 |
284.7 |
285.3 |
13.0 |
16.7 |
3.3 |
3.0 |
0** |
29.0 |
40.0 |
121.7 |
137.7 |
290.0 |
287.0 |
13.3 |
15.7 |
3.0 |
3.7 |
Positive control |
1164.0 |
1139.3 |
1181.3 |
1189.0 |
1179.7 |
1188.0 |
674.0 |
671.7 |
696.0 |
700.3 |
* Scarce background lawn
** Solvent control with DMSO
Table 1 Experiment 1: Exposure 3 hours Harvest 20 hours, with and without activation
Concentration µg/ml |
Metabolic activation |
No. of cells examined |
Mitotic index % mean * |
Cells with aberrations % mean including gaps |
Cells with aberrations % mean excluding gaps |
0* |
- |
200 |
7 |
2 |
0 |
23 |
- |
200 |
6.5 |
2 |
1 |
102 |
- |
200 |
7.6 |
1.5 |
0 |
187 |
- |
200 |
6.3 |
3.5 |
1 |
MMC 0.003 |
- |
200 |
2.8 |
30.5 |
22 |
0* |
+ |
200 |
4.5 |
2 |
0.5 |
59 |
+ |
200 |
4 |
3.5 |
1.5 |
260 |
+ |
200 |
5.6 |
2.5 |
1 |
500 |
+ |
211 |
3.2 |
4.7 |
0 |
CP 3 |
+ |
200 |
2.2 |
19.5 |
12.5 |
Positive controls: MMC Mitomycin C; CP Cyclophosphamide
* Negative control with culture medium
Table 2 Experiment 2: Exposure 3 hours Harvest 20 hours, with and without activation
Concentration µg/ml |
Metabolic activation |
No. of cells examined |
Mitotic index % mean |
Cells with aberrations % mean including gaps |
Cells with aberrations % mean excluding gaps |
0* |
- |
200 |
8.4 |
4.5 |
0.5 |
25 |
- |
200 |
6.4 |
3.1 |
1.4 |
116 |
- |
200 |
6.4 |
1 |
0 |
200 |
- |
200 |
6.7 |
1.5 |
0 |
MMC 0.003 |
- |
200 |
4.5 |
28 |
21.5 |
0* |
+ |
200 |
5.1 |
1.5 |
0.5 |
59 |
+ |
200 |
4.9 |
4.5 |
2 |
260 |
+ |
200 |
3.6 |
4 |
1.5 |
511 |
+ |
211 |
3.6 |
2.3 |
0.9 |
CP 3 |
+ |
200 |
2.3 |
18.1 |
15.5 |
Positive controls: MMC Mitomycin C; CP Cyclophosphamide
* Negative control with culture medium
In trials 1 and 2, treatment induced statistically significant increases in mutant frequency relative to the control, but these were within the range of the historical negative control, and not dose related, so were considered to be the result of normal assay variation, and a consequence of low negative control value.
Table 1 Test 1 Mutant frequency - average of 5 flasks
Without S9 mix |
With S9 mix |
||||||
Concentration µg/ml |
Absolute C.E. |
Mutant frequency |
Significance |
Concentration µg/ml |
Absolute C.E. |
Mutant frequency |
Significance |
0 |
88 |
0 |
0 |
91 |
2 |
||
9 |
96 |
5 |
** |
29 |
93 |
2 |
NS |
24 |
91 |
3 |
*** |
60 |
87 |
3 |
NS |
57 |
98 |
0 |
NS |
143 |
89 |
0 |
NS |
98 |
87 |
2 |
* |
228 |
97 |
0 |
NS |
200 |
97 |
2 |
** |
543 |
91 |
3 |
NS |
Positive control 300 |
92 |
279 |
### |
Positive control 10 |
106 |
108 |
### |
Table 2 Test 2 Mutant frequency - average of 5 flasks
Without S9 mix |
With S9 mix |
||||||
Concentration µg/ml |
Absolute C.E. |
Mutant frequency |
Significance |
Concentration µg/ml |
Absolute C.E. |
Mutant frequency |
Significance |
0 |
83 |
0 |
0 |
88 |
2 |
||
12 |
90 |
1 |
NS |
28 |
92 |
5 |
* |
23 |
80 |
2 |
NS |
60 |
87 |
3 |
NS |
56 |
85 |
5 |
** |
138 |
96 |
1 |
NS |
110 |
82 |
0 |
NS |
Positive control 10 |
121 |
135 |
### |
215 |
85 |
4 |
** |
||||
Positive control 300 |
83 |
378 |
### |
Table 3 Test 2c Mutant frequency - average of 5 flasks
With S9 mix |
|||
Concentration µg/ml |
Absolute C.E. |
Mutant frequency |
Significance |
0 |
91 |
1 |
|
233 |
97 |
3 |
* |
534 |
89 |
5 |
* |
Positive control 10 |
93 |
275 |
### |
NS not significant
* statistically significant
** statistically highly significant
*** statistically very highly significant
### highly significant, no statistics performed
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Information is available from reliable studies for all the required in vitro endpoints. There were reliable positive and negative bacterial mutagenicity results: the negative study was selected as key, as it was obtained in a more recent study to the current guideline, and used test substance with a higher degree of purity. In addition, tests in mammalian cells gave negative results.
Tetramethylsilane has been tested in valid and reliable in vitro studies for all the required genetic toxicity endpoints in accordance with OECD Test Guidelines 471, 473 and 476 and in compliance with GLP. The volatility of the substance was taken into account in the studies. For the mammalian cytogenicity assay, exposure was in sealed flasks and an analytical determination of the concentrations by head space analysis was carried out at the end of the incubation period. The statistically significant increase in the number of revertants was neither dose related nor exceeding historical negative control values, and the increase in the presence of S9 was not reproducible. It is concluded that the test substance is negative for mutagenicity to mammalian cells under the conditions of the test.
Justification for classification or non-classification
The available information for the substance indicates that tetramethylsilane (CAS 75 -76 -3) does not induce mutations in bacteria, as the positive result observed in one strain was not observed when test substance with a higher degree of purity was used in a more recent study. In addition, no potential for genetic toxicity was observed when tetramethylsilane was tested in mammalian cells: no evidence of mutagenicity or cytogenicity was seen in mutagenicity and cytogenicity studies. In vivo testing is not considered necessary as the in vitro results are negative overall. It is concluded that classification for mutagenicity is not required according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.